France· FR:63206106
FINGOLIMOD ACCORD 0,5 mg, gélule
A medicinal product containing chlorhydrate de fingolimod, registered in France by ACCORD HEALTHCARE (ESPAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE FINGOLIMOD
- Manufacturer
- ACCORD HEALTHCARE (ESPAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093022592928 plaquettes PVC PVDC aluminium de 1 gélule (dose unitaire)EUR 579.28
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bb768ac4-bf0f-43dd-9c6a-98b9b3bfa0be GET /v1/drugs/bb768ac4-bf0f-43dd-9c6a-98b9b3bfa0be?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63206106",
"date_amm": "2020-06-25",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1450",
"substance": "CHLORHYDRATE DE FINGOLIMOD",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate de fingolimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.